Gravity Analytica

Travere Therapeutics to Present at Upcoming Investor Conferences

TVTX 11.04.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-11

Name of Upcoming Event:Guggenheim Securities Healthcare Innovation Conference

Date of Upcoming Event:2024-11-20

Name of Upcoming Event:Jefferies London Healthcare Conference

Full Press Release SEC Filings Our TVTX Tweets

About Gravity Analytica

Recent Filings

PDF Version

SAN DIEGO,Nov. 04, 2024(GLOBE NEWSWIRE) --Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in November:

Guggenheim Securities Healthcare Innovation ConferenceMonday, November 11, 2024, at2:30 p.m. ET

Jefferies London Healthcare ConferenceWednesday, November 20, 2024, at8:30 a.m. GMT

Live webcasts of the presentations will be accessible on the Investor page of Travere’s website atir.travere.com/events-presentations, and replays will be available for up to 30 days following each event.

AboutTravere TherapeuticsAtTravere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visittravere.com.

Contact:
Investors:888-969-7879IR@travere.com	Media:888-969-7879mediarelations@travere.com

Source: Travere Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com